Last 12 months
Inside the activity.
21 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 11 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 8 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2018 Filed Apr 27, 2021 15:08 UTC |
McCall William HDirector
|
OtherCommon Stock | 47,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002126 · form5-04272021_120452.xml · nonDerivative · entry 1 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 497,093 F1 · shares: Represents distribution of shares owned by an investor but held in an investment fund. Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 21:35 UTC |
McCall William HDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-000657 · s108851_form4.xml · nonDerivative · entry 1 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 21:33 UTC |
Heinrich JohnDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-000655 · s108849_form4.xml · nonDerivative · entry 1 Heinrich John · CIK 0001669988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,940 Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 21:36 UTC |
O'Rear SamuelDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-000659 · s108853_form4.xml · nonDerivative · entry 1 O'Rear Samuel · CIK 0001670026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,570 Read SEC document |
| January 25, 2018 Filed Jan 30, 2018 02:37 UTC |
Petrelli Anthony BenedictDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-000660 · s108854_form4.xml · nonDerivative · entry 1 Petrelli Anthony Benedict · CIK 0001354750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,013 Read SEC document |
| January 25, 2018 Filed Jan 30, 2018 02:36 UTC |
Sardano MichaelGeneral Counsel
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.55 | $0.00 |
DisclosureSEC source: 0001615774-18-000658 · s108852_form4.xml · derivative · entry 1 Sardano Michael · CIK 0001720602 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-01-25 F1 · derivative.exercise_price: The exercise price was determined based on the closing price of the issuer's common stock on the Nasdaq Stock Market on the date of grant. F2 · shares: The options vest in four equal annual installments beginning on the first anniversary of the date of grant. F2 · derivative.exercise_date: The options vest in four equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| January 25, 2018 Filed Jan 30, 2018 02:34 UTC |
Levine ArthurChief Financial Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 55,334 | $0.00 Strike: $5.55 | $0.00 |
DisclosureSEC source: 0001615774-18-000656 · s108850_form4.xml · derivative · entry 1 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,334 Underlying: Common Stock · 55,334 shares Expires 2028-01-25 F1 · derivative.exercise_price: The exercise price was determined based on the closing price of the issuer's common stock on the Nasdaq Stock Market on the date of grant. F2 · shares: The options vest in four equal annual installments beginning on the first anniversary of the date of grant. F2 · derivative.exercise_date: The options vest in four equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| January 11, 2018 Filed Feb 8, 2019 21:11 UTC |
Petrelli Anthony BenedictDirector
|
Exercise / conversionCommon Stock Warrants · Derivative | 26,614 | $0.00 Strike: $4.58 | $0.00 |
DisclosureSEC source: 0001415889-19-000143 · form5-02082019_010206.xml · derivative · entry 3 Petrelli Anthony Benedict · CIK 0001354750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,614 shares Expires 2018-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2018 Filed Feb 8, 2019 21:11 UTC |
Petrelli Anthony BenedictDirector
|
Tax withholdingCommon Stock | 22,161 | $5.50 | $121,885.50 |
DisclosureSEC source: 0001415889-19-000143 · form5-02082019_010206.xml · nonDerivative · entry 2 Petrelli Anthony Benedict · CIK 0001354750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,466 F1 · security: Cashless exercise of warrants. Read SEC document |
| January 11, 2018 Filed Feb 8, 2019 21:11 UTC |
Petrelli Anthony BenedictDirector
|
Exercise / conversionCommon Stock | 26,614 | $4.58 | $121,892.12 |
DisclosureSEC source: 0001415889-19-000143 · form5-02082019_010206.xml · nonDerivative · entry 1 Petrelli Anthony Benedict · CIK 0001354750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Cashless exercise of warrants. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 12:37 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 4,183 | $6.00 | $25,098.00 |
DisclosureSEC source: 0001615774-17-006044 · s107934_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 960,649 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.01. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 12:38 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 4,183 | $6.00 | $25,098.00 |
DisclosureSEC source: 0001615774-17-006046 · s107935_form4.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 960,649 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.01. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 12:42 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 4,183 | $6.00 | $25,098.00 |
DisclosureSEC source: 0001615774-17-006050 · s107937_form4.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 960,649 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.01. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 16:40 UTC |
Sardano Joseph CDirector · Chief Executive Officer
|
SaleCommon Stock | 6,953 | $6.00 | $41,718.00 |
DisclosureSEC source: 0001615774-17-006048 · s107936_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,587,701 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.01. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 16:35 UTC |
Levine ArthurChief Financial Officer
|
SaleCommon Stock | 217 | $6.00 | $1,302.00 |
DisclosureSEC source: 0001615774-17-006042 · s107933_form4.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,793 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.01. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 13, 2017 Filed Sep 19, 2017 14:03 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 2,114 | $6.00 | $12,684.00 |
DisclosureSEC source: 0001615774-17-005189 · s107548_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 13, 2017 Filed Sep 19, 2017 14:02 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 2,114 | $6.00 | $12,684.00 |
DisclosureSEC source: 0001615774-17-005187 · s107547_form4.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 13, 2017 Filed Sep 19, 2017 14:00 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 2,114 | $6.00 | $12,684.00 |
DisclosureSEC source: 0001615774-17-005185 · s107546_form4.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 13, 2017 Filed Sep 19, 2017 18:05 UTC |
Sardano Joseph CDirector · Chief Executive Officer
|
SaleCommon Stock | 3,512 | $6.00 | $21,072.00 |
DisclosureSEC source: 0001615774-17-005191 · s107549_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,594,654 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 13, 2017 Filed Sep 19, 2017 17:58 UTC |
Levine ArthurChief Financial Officer
|
SaleCommon Stock | 110 | $6.00 | $660.00 |
DisclosureSEC source: 0001615774-17-005182 · s107545_form4.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,010 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 14:50 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 1,561 | $6.00 | $9,366.00 |
DisclosureSEC source: 0001615774-17-005050 · s107487_form4.xml · nonDerivative · entry 3 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,946 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 14:49 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 1,561 | $6.00 | $9,366.00 |
DisclosureSEC source: 0001615774-17-005048 · s107486_form4.xml · nonDerivative · entry 3 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,946 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 14:48 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 1,561 | $6.00 | $9,366.00 |
DisclosureSEC source: 0001615774-17-005046 · s107485_form4.xml · nonDerivative · entry 3 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,946 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 18:53 UTC |
Levine ArthurChief Financial Officer
|
SaleCommon Stock | 82 | $6.00 | $492.00 |
DisclosureSEC source: 0001615774-17-005054 · s107489_form4.xml · nonDerivative · entry 3 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,120 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 18:52 UTC |
Sardano Joseph CDirector · Chief Executive Officer
|
SaleCommon Stock | 2,595 | $6.00 | $15,570.00 |
DisclosureSEC source: 0001615774-17-005052 · s107488_form4.xml · nonDerivative · entry 3 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,598,166 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 08, 2017 Filed Sep 13, 2017 14:50 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 3,002 | $6.00 | $18,012.00 |
DisclosureSEC source: 0001615774-17-005050 · s107487_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,507 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 08, 2017 Filed Sep 13, 2017 14:49 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 3,002 | $6.00 | $18,012.00 |
DisclosureSEC source: 0001615774-17-005048 · s107486_form4.xml · nonDerivative · entry 2 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,507 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 08, 2017 Filed Sep 13, 2017 14:48 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 3,002 | $6.00 | $18,012.00 |
DisclosureSEC source: 0001615774-17-005046 · s107485_form4.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,507 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 08, 2017 Filed Sep 13, 2017 18:53 UTC |
Levine ArthurChief Financial Officer
|
SaleCommon Stock | 155 | $6.00 | $930.00 |
DisclosureSEC source: 0001615774-17-005054 · s107489_form4.xml · nonDerivative · entry 2 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,202 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 08, 2017 Filed Sep 13, 2017 18:52 UTC |
Sardano Joseph CDirector · Chief Executive Officer
|
SaleCommon Stock | 4,990 | $6.00 | $29,940.00 |
DisclosureSEC source: 0001615774-17-005052 · s107488_form4.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600,761 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 07, 2017 Filed Sep 13, 2017 14:50 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 2,771 | $6.00 | $16,626.00 |
DisclosureSEC source: 0001615774-17-005050 · s107487_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 971,509 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 07, 2017 Filed Sep 13, 2017 14:49 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 2,771 | $6.00 | $16,626.00 |
DisclosureSEC source: 0001615774-17-005048 · s107486_form4.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 971,509 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 07, 2017 Filed Sep 13, 2017 14:48 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 2,771 | $6.00 | $16,626.00 |
DisclosureSEC source: 0001615774-17-005046 · s107485_form4.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 971,509 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 07, 2017 Filed Sep 13, 2017 18:53 UTC |
Levine ArthurChief Financial Officer
|
SaleCommon Stock | 144 | $6.00 | $864.00 |
DisclosureSEC source: 0001615774-17-005054 · s107489_form4.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,357 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 07, 2017 Filed Sep 13, 2017 18:52 UTC |
Sardano Joseph CDirector · Chief Executive Officer
|
SaleCommon Stock | 4,607 | $6.00 | $27,642.00 |
DisclosureSEC source: 0001615774-17-005052 · s107488_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605,751 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 19:36 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 2,250 | $6.00 | $13,500.00 |
DisclosureSEC source: 0001615774-17-004954 · s107421_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 974,280 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 19:35 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 2,250 | $6.00 | $13,500.00 |
DisclosureSEC source: 0001615774-17-004953 · s107420_form4.xml · nonDerivative · entry 2 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 974,280 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 19:35 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 2,250 | $6.00 | $13,500.00 |
DisclosureSEC source: 0001615774-17-004952 · s107419_form4.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 974,280 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 23:37 UTC |
Sardano Joseph CDirector · Chief Executive Officer
|
SaleCommon Stock | 3,741 | $6.00 | $22,446.00 |
DisclosureSEC source: 0001615774-17-004955 · s107422_form4.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,610,358 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 23:34 UTC |
Levine ArthurChief Financial Officer
|
SaleCommon Stock | 117 | $6.00 | $702.00 |
DisclosureSEC source: 0001615774-17-004951 · s107418_form4.xml · nonDerivative · entry 2 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,501 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 19:36 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 5,762 | $6.00 | $34,572.00 |
DisclosureSEC source: 0001615774-17-004954 · s107421_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,530 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.05. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 19:35 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 5,762 | $6.00 | $34,572.00 |
DisclosureSEC source: 0001615774-17-004953 · s107420_form4.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,530 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.05. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 19:35 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 5,762 | $6.00 | $34,572.00 |
DisclosureSEC source: 0001615774-17-004952 · s107419_form4.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,530 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.05. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 23:37 UTC |
Sardano Joseph CDirector · Chief Executive Officer
|
SaleCommon Stock | 9,579 | $6.00 | $57,474.00 |
DisclosureSEC source: 0001615774-17-004955 · s107422_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,614,099 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.05. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 23:34 UTC |
Levine ArthurChief Financial Officer
|
SaleCommon Stock | 300 | $6.00 | $1,800.00 |
DisclosureSEC source: 0001615774-17-004951 · s107418_form4.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,618 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.05. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 15:36 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 1,291 | $6.00 | $7,746.00 |
DisclosureSEC source: 0001615774-17-004832 · s107374_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 982,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 15:34 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 1,291 | $6.00 | $7,746.00 |
DisclosureSEC source: 0001615774-17-004828 · s107372_form4.xml · nonDerivative · entry 2 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 982,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 15:35 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 1,291 | $6.00 | $7,746.00 |
DisclosureSEC source: 0001615774-17-004830 · s107373_form4.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 982,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 19:32 UTC |
Sardano Joseph CDirector · Chief Executive Officer
|
SaleCommon Stock | 2,143 | $6.00 | $12,858.00 |
DisclosureSEC source: 0001615774-17-004826 · s107371_form4.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,623,678 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 19:30 UTC |
Levine ArthurChief Financial Officer
|
SaleCommon Stock | 67 | $6.00 | $402.00 |
DisclosureSEC source: 0001615774-17-004824 · s107370_form4.xml · nonDerivative · entry 2 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,918 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.